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A b s t r a c t
Background: Red cell distribution width (RDW) is a measurement of size variability of the red blood cells and has been shown 
to be a powerful predictor of prognosis in heart failure (HF). Recently, global longitudinal strain (GLS) emerged as a more 
accurate marker of left ventricular (LV) systolic function. 
Aim: We aimed to assess the relationship between RDW and standard echocardiographic parameters and LV global strain 
measured by two-dimensional (2D) speckle tracking echocardiography in patients with HF with reduced EF (HFrEF).
Methods: Fifty-nine HF patients with an EF < 50%, and 40 age-matched controls with normal EF were included in the study. 
Standard and 2D strain imaging examinations were performed. Blood tests including RDW were scheduled on the same day 
as the echocardiographic study.
Results: Left atrial volume index, LV end-systolic and end-diastolic dimensions, and E/A and E/e’ ratios were higher and LVEF 
together with LV GLS were significantly lower in the HFrEF group. RDW showed positive correlations with log B-type natri-
uretic peptide (r = 0.45, p = 0.0001), left atrial volume index (r = 0.38, p = 0.001), LV end-diastolic dimensions (r = 0.37, 
p = 0.001), and E/e’ (r = 0.33, p = 0.005) and negative correlations with haemoglobin (r = –0.54, p = 0.0001), LVEF 
(r = –0.27, p = 0.004) and finally LV GLS (r = –0.41, p = 0.001). HFrEF patients were divided into two groups based on the 
median RDW value. Patients with higher than median RDW had significantly lower GLS despite similar EF. 
Conclusions: Elevated RDW is associated with poorer LV deformation assessed by speckle tracking echocardiography in HF 
patients with similar EF. Therefore, the degree of anisocytosis could be used as an additional marker to identify these high-risk 
patients as well as improve treatment strategy. 
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INTRODUCTION
Red cell distribution width (RDW) is a measurement of size 
variability of the red blood cells that can be easily measured 
by automated laboratory equipment as a component of 
complete blood count. Recently, RDW has been shown to 
be a powerful predictor of prognosis in heart failure (HF) 
with reduced ejection fraction (EF) — HFrEF; however, its 
relationship with the degree of the left ventricular (LV) dys-
function remains to be clarified [1, 2]. Echocardiography is 
the method of choice for the assessment of ventricular func-
tion, the diagnosis and the follow-up of HF. Strain imaging is 
an established technique for the accurate quantification of 
ventricular function and LV global longitudinal strain (GLS) 
has been shown to be a superior marker of contractility than 
EF [3, 4]. In this study we aimed to assess the relationship 
between RDW and standard echocardiographic parameters 
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and LV GLS measured by speckle tracking echocardiography 
in patients with HFrEF.
METHODS
Study population
Fifty-nine HF patients with an EF < 50% and 40 age-matched 
controls with normal EF were included in the study. Exclusion 
criteria were defined as the presence of known haematologi-
cal diseases such as haemolytic anaemia, chronic obstructive 
pulmonary disease, malignancy, neoplastic metastasis in the 
bone marrow, any thyroid or liver dysfunction, infectious 
diseases, pregnancy, severe arthritis and inflammatory bowel 
diseases, and any medication that could potentially interfere 
with the measurement of RDW. The study was approved 
by our Local Ethics Committee, and informed consent was 
obtained from all participants.
Echocardiographic study
Standard and two-dimensional (2D) strain imaging examina-
tions were performed using a Philips ultrasound system (Epic 
7.0, Philips Healthcare, Inc., Andover, MA) equipped with 
a 1–5 MHz X5-1 transducer and tissue Doppler imaging 
technology. At least two consecutive heartbeats were ana-
lysed with values represented as mean values. All standard 
2D transthoracic echocardiographic images were obtained. 
Left atrial volume was measured and indexed to the body 
surface area. LV end-systolic (LVESD) and end-diastolic di-
mensions (LVEDD) were calculated from M-mode recordings 
in the parasternal long axis view. LVEF was assessed by using 
bi-plane Simpson method. Mitral early (E) and late (A) inflow 
velocities were measured by pulsed wave Doppler, and an 
E/A ratio was calculated. 
Mitral annular peak early (E’) and late (A’) diastolic veloci-
ties were measured by pulsed wave tissue Doppler imaging 
from the septal and lateral mitral annulus and averaged. The 
E/E’ ratio was calculated to estimate LV filling pressures. 
For the assessment of longitudinal strain, standard 2D 
ultrasound images were recorded with a frame rate between 
60 and 80 frames per second from the apical long axis, and 
two- and four-chamber views. These recordings were then 
stored digitally for offline analysis. In short, a semi-automatic 
algorithm was used for tracking the LV myocardial wall. First 
the LV endocardial border manually defined. Then the en-
docardium was automatically tracked throughout the cardiac 
cycle. The LV GLS was obtained by averaging all segmental 
strain values of three apical views. Peak systolic strain was 
defined as a peak negative value on the strain curve before the 
aortic valve closure (Fig. 1). All measurements were made by 
an expert echocardiographer blinded to clinical information 
of the patients. Because the GLS values are negative, a lower 
absolute number represents a worse value.
Laboratory measurements
Peripheral venous blood samples were obtained for routine 
chemistry including creatinine, haemoglobin, and RDW after 
an over-night fast. B-type natriuretic peptide (BNP) measure-
ment was performed only for the HFrEF patients. Blood tests 
were scheduled on the same day as the echocardiographic 
study, and the analysis was performed with a Beckman Coulter 
analyser (Pasadena, California, United States).
Figure 1. Representative examples of acquisition and analysis of global longitudinal strain (GLS) in a control subject (upper panel) 
and a patient with heart failure with reduced ejection fraction (HFrEF) (lower panel). Strain is measured from apical two chamber 
(A), four chamber (B), and three chamber (C) views. Peak systolic strain is defined as the most negative value before aortic valve 
closure. GLS is the average of the peak systolic strain acquired from three apical views. Seventeen segment bulls-eye plots of left 
ventricular strain are built automatically by the software at the end of the analysis (D). Note the difference between the control 
subject with normal GLS (–21%) and the HFrEF patient with severely decreased average GLS (–5%) 
A B C D
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Statistical analysis
Data management and analysis were performed using SPSS 
Statistics version 17.0 (SPSS Inc., Chicago, IL). Continuous 
variables are expressed as mean ± standard deviation (SD) or 
median with interquartile range (IQR) according to the vari-
able distribution. Normal distributions were confirmed using 
the Kolmogorov-Smirnov test. We used the c2 test for differ-
ences in categorical factors between the groups. Comparisons 
of continuous variables were performed using independent 
samples t-test for normally distributing variables, otherwise 
the Mann-Whitney U test was applied to test the differences 
between groups. Correlations of RDW with various clinical 
and echocardiographic parameters were tested by Pearson 
or Spearman’s correlation analysis, as appropriate. A p-value 
< 0.05 was considered statistically significant.
RESULTS
Fifty-nine HFrEF patients fulfilled the inclusion criteria (50 had 
ischaemic and nine had non-ischaemic cardiomyopathy). 
All patients were receiving guideline-recommended medical 
treatment and were clinically stable with New York Heart 
Association (NYHA) class II functional capacity. The clinical 
characteristics of HFrEF patients and the control group are 
shown in Table 1. There were no differences regarding the 
gender and age of the subjects. Systolic blood pressure (SBP) 
and plasma haemoglobin levels were significantly lower, while 
creatinine and RDW were significantly higher in HFrEF pa-
tients. The echocardiographic data are shown in Table 2. Left 
atrial volume index (LAVI), LV dimensions, and E/A and E/e’ 
ratios were higher and LVEF and LV GLS were significantly 
lower in the HFrEF group. 
Red cell distribution width showed significant correlations 
with various laboratory and echocardiographic parameters. As 
the distribution of BNP was not normal within the HFrEF group, 
“log-transformation” of BNP (log-BNP) was used for further 
statistical analysis. There were positive correlations with log 
BNP (r = 0.45, p = 0.0001), LAVI (r = 0.38, p = 0.001), 
LVEDD (r = 0.37, p = 0.001), and E/e’ (r = 0.33, p = 0.005) 
and negative correlations with haemoglobin (r = –0.54, 
p = 0.0001), LVEF (r = –0.27, p = 0.004), and finally LV 
GLS (r = –0.41, p = 0.001). From the echocardiographic pa-
rameters measured, LV GLS showed the strongest correlation 
with RDW. The correlation analysis is presented in Table 3. 
Subsequently, HFrEF patients were divided into two groups 
based on the median RDW value (Table 4). Patients with higher 
than median RDW had significantly lower GLS compared to 
patients with lower than median RDW, despite similar EF. 
DISCUSSION
In this study, first we assessed the level of RDW in normal 
subjects and patients with HFrEF, then we investigated the 
association between the RDW levels and echocardiographic 
parameters of LV function, namely GLS, a quantitative marker 
of LV systolic function in an ambulatory HFrEF patient popula-
tion.  In accordance with previous studies [1–4], we demon-
strated that mean RDW level was significantly elevated in the 
HFrEF group compared with controls. 
Red cell distribution width is a quantitative measure of 
anisocytosis, which is the variability in the size of the circu-
lating erythrocytes, and is routinely measured by automated 
laboratory equipment used to perform complete blood counts 
[5]. There are several haematological reasons for elevated 
RDW, including iron deficiency anaemia, haemolytic dis-
orders, thrombotic thrombocytopenic purpura [6, 7], and 
non-haematological causes such as colon cancer, inflam-
matory bowel disease, pulmonary hypertension, and aortic 
Table 1. Comparison of demographic properties and clinical 






Age [year] 57 ± 13 53 ± 8 NS
Gender (male) 77% 63% NS
Systolic BP [mmHg] 109.9 ± 9.4 121 ± 10.2 0.02
Diastolic BP [mmHg] 70 (60–85) 73 (60–89) NS
Creatinine [mg/dL] 0.98 (0.8–1.3) 0.8 (0.7–0.9) 0.03
Uric acid [mg/dL] 6.9 ± 1.9 5.4 ± 0.7 NS 
Haemoglobin [g/dL] 12.6 ± 2 14.1 ± 1 0.01
RDW [%] 15 (13.8–17.5) 13.7 (13.2–14.2) 0.0001
Data shown as mean and standard deviation, mean and interquartile 
range or percentage. HFrEF — heart failure with reduced ejection 
fraction; BP — blood pressure; RDW — red cell distribution width;  
NS — nonsignificant
Table 2. Comparison of echocardiographic parameters of 
HFrEF patients and control group
HFrEF group 
(n = 59)
Control group  
(n = 40)
p
LVEDD [mm] 65 (57–69) 48 (45–50) 0.0001
LVESD [mm] 49 (43–56) 28 (26–32) 0.0001
LVEF [mm] 34 (26–40) 65.5 (64–67) 0.0001
E [mm/s] 76 ± 24 65 ± 17 0.01
A [mm/s]* 55 ± 25 72 ± 13 0.0001
E/A* 1.4 (0.7–3) 0.9 (0.8–1.1) 0.001
e’ [cm/s] 5.3 ± 1.3 10.5 ± 1.8 0.0001
E/e’ 17 ± 6 10 ± 3 0.0001
LAVI [mL/m2] 42.7 ± 22.1 28.2 ± 9.6 0.0001
LV GLS [%] –9 ([–7]–[–13]) –20 ([–18]–[–25]) 0.0001
Data shown as mean and standard deviation or mean and interquartile 
range. *The measurements were available for 45 patients in the heart 
failure with reduced ejection fraction (HFrEF) group; LVEDD — left ven-
tricular end-diastolic dimension; LVESD — left ventricular end-systolic 
dimension; LVEF — left ventricular ejection fraction; E — mitral early 
diastolic inflow velocity; A — mitral late diastolic inflow velocity;  
e’ — mitral annular early diastolic tissue velocity; LAVI — left atrial 
volume index; LV GLS — left ventricular global longitudinal strain
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Table 4. Comparison of clinical characteristics and echocardiographic parameters of HFrEF patients grouped based on the  
median red cell distribution width (RDW) value
Lower than median RDW group 
(n = 29)
Higher than median RDW group 
(n = 30)
p
Age [years] 60 ± 10 55 ± 14 NS
Gender (male) 82% 70% NS
Log BNP 2.5 ± 0.3 2.6 ± 0.3 NS
Creatinine [mg/dL] 0.98 (0.52–1.54) 0.99 (0.55–6.07) NS
Haemoglobin [g/dL] 13.5 ± 1.5 11.5 ± 2.1 0.001
Systolic BP [mmHg] 109.7 ± 9 110 ± 10 NS
Diastolic BP [mmHg] 70 (60–80) 70 (60–85) NS
Atrial fibrillation 18 (5%) 30 (9%) NS
LVEDD [mm] 62.3 ± 0.9 64.1 ± 0.8 NS
LVESD [mm] 47 ± 1.0 51 ± 0.7 NS
LVEF [%] 34 ± 9 31 ± 9 NS
E [mm] 69 ± 21 83 ± 25 0.04
A [mm]* 61 ± 24 43 ± 25 0.02
E/A* 1.9 ± 2.3 2.3 ± 1.3 NS
e’ [cm/s] 5.4 ± 1.4 5.2 ± 1.1 NS
E/e’ 16.7 ± 5.7 18.5 ± 7.5 NS
LAVI [mL/m2] 41.1 ± 19 43.18 ± 22 NS
LV GLS [%] –12 ± 4 –8 ± 3 0.001
Data shown as mean and standard deviation; mean and interquartile range, or number (percentage). *The measurements were available for  
24 patients with “lower” and 21 patients with “higher” RDW. HFrEF — heart failure with reduced ejection fraction; Log BNP — log transforma-
tion of B-type natriuretic peptide; BP — blood pressure; LVEDD — left ventricular end-diastolic dimension; LVESD — left ventricular end-systolic 
dimension; LVEF — left ventricular ejection fraction; E — mitral early diastolic inflow velocity; A — mitral late diastolic inflow velocity; e’ — mitral 
annular early diastolic tissue velocity; LAVI — left atrial volume index; LV GLS — left ventricular global longitudinal strain; NS — nonsignificant
Table 3. Correlation analysis of biochemical and echocardiographic variables and red cell distribution width
Variable Correlation
r p 
Age [years] –0.161 0.22
Haemoglobin [g/dL] –0.54 0.0001
Log BNP 0.451 0.0001
WBC [/µL] –0.072 0.63
Creatinine [mg/dL] 0.053 0.726
CRP [mg/dL] –0.188 0.307
E [cm/s] 0.187 0.24
A [cm/s] –0.20 0.07
E/A 0.144 0.36
E/e’ 0.33 0.005
LVEF [%] –0.27 0.004
LVEDD [mm] 0.371 0.001
LVESD [mm] 0.222 0.091
LAVI [mL/m2] 0.383 0.001
LV GLS [%] 0.415 0.001
Log BNP — log transformation of B-type natriuretic peptide; WBC — white blood cell count; CRP — C reactive protein; E — mitral early diastolic 
inflow velocity; A — mitral late diastolic inflow velocity; e’ — mitral annular early diastolic tissue velocity; LVEF — left ventricular ejection fraction; 
LVESD — left ventricular end-systolic dimension; LVEDD — left ventricular end-systolic dimension; LAVI — left atrial volume index; LV GLS — left 
ventricular global longitudinal strain
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valve surgery [8–10]. Recently, RDW has been regarded as 
a promising marker for predicting the onset and evolution of 
HF [11]. In two population-based prospective studies includ-
ing subjects without cardiovascular diseases, patients with the 
highest RDW quartiles exhibited a significantly increased risk 
of developing HF [12, 13].
Regarding to the prognostic value of RDW in patients with 
HF, it has been concluded that RDW independently predicts 
one-year mortality in acute HF patients, as well as in patients 
with chronic HF [14, 15]. High RDW values also predict poor 
long-term outcome regardless of anaemia status in HF patients 
[16]. There are no clear conjectural mechanisms to explain 
the relationship between RDW and cardiovascular diseases 
yet. Among a number of potential factors, chronic inflam-
mation, oxidative stress, and neurohormonal activation have 
been hypothesised to play a significant role. Previous studies 
demonstrated that inflammation causes myelosuppression, 
decreases renal erythropoietin synthesis, and triggers apoptosis 
of erythroid precursors in bone marrow, which may result in 
a higher degree of anisocytosis, and thereby a higher RDW 
value [17]. In accordance with this data, our results suggest 
that RDW has a strong negative correlation with haemoglobin 
and a positive correlation with BNP in HFrEF patients.  
Although there is increasing evidence uniformly sup-
porting the prognostic importance of RDW in HF, findings 
about the association between RDW and the degree of 
ventricular dysfunction have not been consistent. Oh et al. 
[18] reported an independent correlation between RDW 
and echocardiographic signs of diastolic dysfunction (E/E’) in 
acute HF patients. In another study by Al-Naijar et al. [19], 
increasing RDW was shown to be associated with worsen-
ing cardiac function, which is defined as increasing NYHA 
functional class in HF population. In our study, although all 
of the patients were in similar NYHA functional class, RDW 
showed close correlation with echocardiographic indicators 
of diastolic dysfunction such as increased LVEDD, LAVI, E/A, 
and E/e’, as well as systolic dysfunction such as reduced EF 
and GLS. Within these echocardiographic parameters, GLS 
had the most significant correlation with RDW.
In order to compare the laboratory and echocardio-
graphic parameters between HFrEF patients with “higher” 
and “lower” RDW levels, we divided the patients according 
to the median RDW. Interestingly, despite having similar EF, 
patients with higher than median RDW exhibited a worse 
ventricular systolic function reflected by severely reduced GLS. 
Speckle tracking echocardiography offers a multidimensional 
assessment of myocardial contraction [20] and represents 
myocardial deformation rather than volumetric change as seen 
by the LVEF method. GLS, obtained by 2D speckle tracking 
echocardiography, has previously been demonstrated to be 
superior to EF in various cardiac diseases [21, 22]. 
Although there is no established absolute value for GLS 
that indicates high risk in HF, recently published data suggest 
that worsening GLS is a manifestation of advanced degree of 
systolic dysfunction and adverse prognosis in HFrEF patients 
independent from EF [23]. Recently, GLS also appeared to be 
a better prognosticator and showed a closer relation with BNP 
than EF in HFrEF patients [24, 25]. Accordingly, despite having 
similar standard echocardiographic parameters including EF, 
patients with higher RDW had significantly less favourable 
GLS in our study.
Limitations of the study
This study had some limitations. First, the size of the study 
population was relatively small to compare the echocardio-
graphic parameters between different quartiles of RDW, which 
could enable a more explicit observation of the relation be-
tween increasing RDW and worsening GLS. Second, although 
we excluded several haematological and non-haematological 
conditions that could affect RDW, the study population in-
cluded patients with mild degree of anaemia due to chronic 
disease, which might cause potential interference between 
haemoglobin and RDW levels. Third, we measured the LVEDD 
and LVESD based on M-mode recordings and calculated the 
EF with the biplane Simpson method on echocardiography. 
The volumetric measurement of EF with cardiac magnetic 
resonance imaging or three-dimensional echocardiography 
is more accurate; however, those techniques are not suitable 
for  follow-up of these patients in routine clinical practice. 
Finally, we did not demonstrate the precise mechanism of 
association between RDW and systolic deformation. Further 
studies are required to answer the key question of whether 
the association between RDW and LV systolic deformation is 
casual or if elevated RDW occurs as a consequence of underly-
ing metabolic alterations that are commonly observed in HF.
CONCLUSIONS
In conclusion, elevated RDW is associated with poorer LV 
deformation assessed by speckle tracking echocardiography 
in HF patients with similar EF. Therefore, the degree of an-
isocytosis could be used as an additional marker to identify 
these high-risk patients  as well as improve treatment strategy. 
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